How it works
Agreement to provide a fully-automated solution (CLIA) for Hepatitis A, B, C and HIV tests in the U.S. on the LIAISON platforms. DiaSorin and Beckman Coulter are working together to get the approval from the Food and Drug Administration (FDA) to market these CLIA test in the U.S. territory.
Our complete menu of Hepatitis and HIV products available on the LIAISON XL coupled with the Beckman Coulter leadership in the TLA market will offer our customers an ideal solution to address the issues created in the labs by the increase of testing volume related to the ongoing consolidation of testing sites.
Launch of Hepatitis & Retroviruses panel in the U.S., leveraging on Beckman Coulter penetration in Large Labs and state-of-the-art technology tests by DiaSorin.
How it connects with the strategy
Increase penetration in the U.S. reinforcing collaboration with strategic partners.